Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is internationally recognized for her expertise in cannabis and cannabinoids. Her current work focuses on: (1) conducting placebo-controlled studies testing the efficacy of potential treatment medications for Cannabis Use Disorder, and (2) testing the potential therapeutic effects of cannabis and its constituents for a range of indications, including pain and appetite-enhancement. Dr. Haney’s research has been continuously supported by the National Institute of Health (NIH) since 1999. She has authored over 180 scientific publications, is an Associate Editor for Cannabis and Cannabinoid Research, is an Advisory Editor for Psychopharmacology, and co-edited Neuropsychopharmacology Reviews 2018, Cannabis and Cannabinoids: From Synapse to Society. Dr. Haney has been a longstanding participant in NIH review groups and has been on several NIH advisory councils, is an elected Fellow at the American College of Neuropsychopharmacology and is a past President of the College on Problems of Drug Dependence (2019). Her contributions to research have been recognized by both the Center for Medicinal Cannabis Research and the College on Problems of Drug Dependence.

Previous Webinars

Andrew Maxwell Phineas Jones, PhD

July 15th @ 11:00AM MT

Ten years of Cannabis micropropagation: What has changed and what are the best uses

 Dr. A.M.P. (Max) Jones is a professor and leading researcher in cannabis biotechnology at the University of Guelph, Canada. For the last decade his research has focused on plant tissue culture and micropropagation systems for cannabis and in 2018 his lab […]

Read More »

Kent Hutchison

July 9, 2026, 1 PM Moutain Time

Dr. Kent Hutchison is a Professor of Psychiatry at the University of Colorado Anschutz Medical Campus and Director of the Rocky Mountain Center for Cannabis Research. He received his Ph.D. from Oklahoma State University, completed postdoctoral training at Brown University, and has developed NIH-funded programs of research spanning alcohol, […]

Read More »

Tony P. George, MD, FRCPC

June 11, 2026 at 1 PM MDT

Understanding the links between cannabis use and mental illness: Implications for treatment

 

Dr. George is Professor of Psychiatry in the Temerty Faculty of Medicine at the University of Toronto (UofT), and Senior Scientist at the Centre for Addiction and Mental Health (CAMH). He received his B.Sc. (1988) and M.D. (1992) degrees from […]

Read More »

Jacob MacWilliams, Ph.D.

May 20, 2026 11:00AM MDT

Unlocking the mystery of a key hemp pest, cannabis aphid

Dr. Jacob MacWilliams is a research scientist in Dr. Punya Nachappa’s lab in the Agricultural Biology Department at Colorado State University. Jacob received his Ph.D. in Biochemistry and Molecular Biology at the University of California, Riverside focusing on cowpea aphid resistance in […]

Read More »

Shanna Bablonis, Ph.D.

Cannabis and Opioid Interactions: Human Laboratory Studies and Clinical Implications

May 14, 2026 1:00PM MDT

Shanna Babalonis, PhD is an associate professor in the University of Kentucky (UK) College of Medicine Department of Behavioral Science and Center on Drug and Alcohol Research. Her NIH-funded research focuses on clinical trials and human laboratory assessments of the abuse potential, […]

Read More »

Michael Petersen

Apr 15, 2026 11:00 AM Mountain Time

Trait Modifications in Cannabis Through Engineering and Editing

Michael Petersen has over 40 years of experience as a researcher and mentor in the plant biotech space. He worked for 10 years at Agracetus, a small startup in Wisconsin and then 20 years as a Senior Fellow with Monsanto. Mike stayed […]

Read More »